R

Rhythm Pharmaceuticals Inc. Tech Stack

Commercial-stage biotech focused on rare neuroendocrine diseases and MC4R pathway treatment

Biotechnology Research Boston, MA 201–500 employees Founded 2008 Public Company

Rhythm Pharmaceuticals is a public biotech company commercializing treatments for rare metabolic and neuroendocrine diseases, with active programs in MC4R pathway disorders and congenital hyperinsulinism. The hiring mix—weighted toward healthcare (8), ops (7), and sales (7) roles at manager+ levels—reflects a company scaling post-launch commercialization and patient support infrastructure. Pain points centered on patient service efficiency, data standardization across regions, and payer access suggest operational maturity challenges typical of early-commercial biotech expanding geographically.

Tech Stack 24 technologies

Core StackSalesforce Snowflake Power BI Python AWS Linux Azure AD WordPress ADP E*TRADE Microsoft Office SQL ADP Workforce Now Concur GCP WP Engine Windows Azure IAM VPC DNS SSL/TLS Excel Ironclad

What Rhythm Pharmaceuticals Inc. Is Building

◆Challenges

Improving patient service efficiency
Managing outsourced data management
Improving data management processes
Reducing number of undiagnosed patients
Standardizing global ap processes
Improving forecast accuracy
Aligning revenue forecasts across regions
Supporting new indication launches
Access barriers across payer channels
Complex patient access cases

▲Active Projects

Support testing initiatives for rgdo
Clinical study enrollment support
Bbs register development
Regional conferences
Study inspection readiness activities
Disease education for bbs and ho
National meetings
Internal genetic testing programs
Educational webinars
Disease education initiatives

Hiring Activity

Accelerating40 roles · 25 in 30d

Department

Healthcare

8

Ops

7

Sales

7

Data

4

Legal

3

Finance

2

Regulatory

2

Communications

1

Seniority

Manager

19

Senior

14

Director

4

Lead

2

Mid

1

VP

1

Notable leadership hires: National Account Director, Regulatory Lead

Company intelligence

Find more companies like Rhythm Pharmaceuticals Inc. by tech stack, pain points and active projects

Get started free

About Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals develops medicines targeting rare diseases in the MC4R pathway and metabolism space. The company is commercial-stage, with its lead asset already marketed in North America, Europe, and other regions, supported by an active clinical pipeline in related rare indications and preclinical programs in congenital hyperinsulinism. Headquartered in Boston and publicly traded, Rhythm operates across multiple geographies—hiring in the United States, United Kingdom, Netherlands, Germany, Spain, Austria, Switzerland, and Peru—and maintains dedicated healthcare, operations, sales, regulatory, and data functions. The company provides patient support services and disease education alongside pharmaceutical development.

HeadquartersBoston, MA

Company Size201–500 employees

Founded2008

Hiring MarketsNetherlands, United States, Germany, Peru, Spain, United Kingdom, Austria, Switzerland

Frequently Asked Questions

What is Rhythm Pharmaceuticals' lead product and indication?

Rhythm commercializes a lead asset for rare neuroendocrine diseases, with ongoing clinical programs in MC4R pathway disorders and preclinical development in congenital hyperinsulinism. The company markets this asset in North America, Europe, and select other regions.